The basic consolidated EPS for Brainstorm Cell Therapeutics Inc. (NASDAQ:BCLI) for the year ended 2015-12-31 was $-0.4612. For the quarter closed 2015-12-31, the basis consolidated per-share earnings was $-0.4612.

EPS from continuing operations

The basic per-share earnings from continuing operations as confirmed by Brainstorm Cell Therapeutics Inc. (NASDAQ:BCLI) for the period closed 2015-12-31 was $-0.4612. For the quarter ended 2015-12-31, this number was $-0.4612.

For any specified company’s stock there are multiple brokerages tracking the firm and reporting EPS targets. Since last so many years Zacks has been following analyst targets and setting mean EPS targets. This projection is the consensus of all the estimates given by brokerages. Mean targets are considerably positive because they lower the risk associated with sole market analyst target.

EPS contribution from parent

For the year closed 2015-12-31, Brainstorm Cell Therapeutics Inc. (NASDAQ:BCLI) registered basic EPS of $-0.4612 from its parent firm. The contribution from the company for the period closed 2015-12-31 was $-0.4612.

Basic net EPS

For the year closed 2015-12-31, Brainstorm Cell Therapeutics Inc. (NASDAQ:BCLI)’s basic net EPS was $-0.46. The basic net EPS for the quarterly period 2015-12-31 stood at $-0.46.

Consolidated diluted EPS

The consolidated diluted EPS for the year closed 2015-12-31 stood at $-0.4612. For the quarter closed 2015-12-31, consolidated diluted EPS was $-0.4612.

Basic diluted EPS

For the period closed 2015-12-31, diluted EPS from continuing business was $-0.4612. For the quarter closed 2015-12-31, this number was $-0.4612.

Net diluted EPS

Net diluted EPS for the year closed 2015-12-31 was $-0.46. For the quarter closed 2015-12-31, net diluted EPS was $-0.46.

Diluted EPS from parent

From the parent firm, Brainstorm Cell Therapeutics Inc. (NASDAQ:BCLI)’s diluted EPS was $-0.4612 for the period ended 2015-12-31. The diluted per-share earnings from the parent firm for the quarterly period closed 2015-12-31 was $-0.4612.

Brainstorm Cell Therapeutics Inc. (NASDAQ:BCLI) registered net basic EPS of $-0.46 for the year closed 2015-12-31. This figure stood at $-0.46 for the quarter closed 2015-12-31.

The mean basic shares outstanding for the year closed 2015-12-31 is 18.406 and for the quarter closed on 2015-12-31, the figure is 18.406.

For the twelve-monthly period closed 2015-12-31, the diluted shares outstanding is 18.406 and for the quarter closed 2015-12-31 is 18.406.

1 Chart Pattern Every Investor Should Know

This little-known pattern preceded moves of 578% in ARWR, 562% in LCI, 513% in ICPT, 439% in EGRX, 408% in ADDUS and more...